Volunteer contact.

Volunteer contact: A randomized controlled trial on the effectiveness of an individual life-review intervention for people of 65 years and older with mild to moderate depression symptoms.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON25388

Enrollment

135

Registered

2013-04-11

Start date

2013-06-17

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

life-review, randomized controlled trial, depressive symptoms, older adults

Interventions

Intervention Dear memories: An individual life-review intervention which trains participants to retrieve specific, positive memories. The intervention consists of five structured conversations of 45 m

Eligibility

Inclusion criteria

Inclusion criteria: 1. An age of 65 years or older and receiving health within a healthcare organization (by receiving outpatient or home care, or living in a care or nursing home); 2. Presence of clinically relevant depressive symptoms (score of 2 or higher on the GDS-8).

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment, measured by a score of 18 or lower on the Mini Mental State Examination (MMSE, Folstein et al 1975); 2. The diagnosis of major depressive episode (based on the MINI, 8 or 9 of the 9 DSM-IV symptoms of depression); 3. Having started with medication for depressive symptoms within the past 3 months; 4. Poor command of the Dutch language.

Design outcomes

Primary

Measure	Time frame
The primary outcome is depressive symptoms, which will be measured at study entry, post-intervention and follow up. Depressive symptoms will be measured by means of the 8-item Dutch version of the Geriatric Depression Scale (GDS-8; Jongenelis et al., 2007).	—

Secondary

Measure	Time frame
Secondary outcomes, which will be measured at study entry, post-intervention and follow up, are anxiety symptoms, positive mental health, mastery, loneliness, and specific positive memories. Anxiety symptoms will be measured with the Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A, Zigmond & Snaith, 1983). Positive mental health will be measured using the Mental Health Continuum – Short Form (MHC-SF; Lamers et al., 2011). Loneliness will be assessed with a scale developed by de Jong-Gierveld and Kamphuis (1985). Mastery will be assessed with the Pearlin Mastery Scale (Pearlin & Schooler, 1978). Specific, positive memories will be measured using the Autobiographical Memory Test (AMT; Williams & Broadbent, 1986). Other secondary measures, which will be measured at study entry and follow up, are functional limitations, general cognitive functioning and depressive episode. Number of functional limitations were indicated by the Groningen Activity Restrictions Scale (GARS; Kempen et al., 1990). General cognitive functioning will be assessed by means of the 30-item Mini-Mental State Examination (MMSE; Folstein et al., 1975). The presence of major depressive disorder according to DSM-IV criteria will be assessed with The Mini-International Neuropsychiatric Interview (M.I.N.I; Sheehan et al., 1998).	—

Measure

Time frame

Secondary outcomes, which will be measured at study entry, post-intervention and follow up, are anxiety symptoms, positive mental health, mastery, loneliness, and specific positive memories. Anxiety symptoms will be measured with the Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A, Zigmond & Snaith, 1983). Positive mental health will be measured using the Mental Health Continuum – Short Form (MHC-SF; Lamers et al., 2011). Loneliness will be assessed with a scale developed by de Jong-Gierveld and Kamphuis (1985). Mastery will be assessed with the Pearlin Mastery Scale (Pearlin & Schooler, 1978). Specific, positive memories will be measured using the Autobiographical Memory Test (AMT; Williams & Broadbent, 1986). Other secondary measures, which will be measured at study entry and follow up, are functional limitations, general cognitive functioning and depressive episode. Number of functional limitations were indicated by the Groningen Activity Restrictions Scale (GARS; Kempen et al., 1990). General cognitive functioning will be assessed by means of the 30-item Mini-Mental State Examination (MMSE; Folstein et al., 1975). The presence of major depressive disorder according to DSM-IV criteria will be assessed with The Mini-International Neuropsychiatric Interview (M.I.N.I; Sheehan et al., 1998).

—

Contacts

Public ContactJojanneke Korte

P.O. Box 217

j.korte@utwente.nl0651071144

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)